Evaluation of the comparative efficacy of Rasnadi Taila Nasya (Standard control) and Dashmoola Taila Nasya (Trial drug) in the management of Vataja Shirahshoola - an open label double arm randomized clinical trial

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients having the signs and symptoms of Vatika Shirahshoola as given in Ayurvedic classics will be selected.
•Patients should be willing to participate in the trial.

•1. Patients not having vatika shirahshoola.
•2. Age less than 15 and greater than 50 years.
•3. Pregnant and lactating women.
•4.Patients suffering from major systemic diseases viz. T.B., cancer, diabetes mellitus, heart diseases, hypertension.
•5. Headache due to refractive error and increased intra-ocular pressure.
•6. Headache due to involvement of other doshas except vata.
•7. Secondary headache due to other pathological conditions e.g. tumors, cerebral haemorrhagic conditions.
•8. Traumatic injury.
•9. Nasya ayogya patients as per classical texts will be excluded.

发起方